Skip to main content
Clinical Trials/NCT01080911
NCT01080911
Unknown
Phase 4

0.05 vs. 0.1 Milligram Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy With/Without Anterior and Posterior Vaginoplasty

Mahidol University1 site in 1 country72 target enrollmentMarch 2010
ConditionsPain
InterventionsMorphine

Overview

Phase
Phase 4
Intervention
Morphine
Conditions
Pain
Sponsor
Mahidol University
Enrollment
72
Locations
1
Primary Endpoint
the amount of 24 hours morphine
Last Updated
14 years ago

Overview

Brief Summary

This study aims to compare the effect of spinal morphine between the dose 0.05 mg and 0.1 mg on the amount of morphine during the first 24 hours postoperative.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
December 2012
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sirilak Suksompong

Associate Professor

Mahidol University

Eligibility Criteria

Inclusion Criteria

  • Female ASA 1-3
  • Undergoing vaginal hysterectomy with/without anterior and posterior vaginoplasty
  • Can operate PCA device

Exclusion Criteria

  • History of allergy to the study drugs
  • History of bleeding tendency
  • History of infection at the back
  • Patient refuse to have spinal anesthesia
  • History of CAD or CVD

Arms & Interventions

spinal morphine 0.05 mg

spinal morphine 0.05 mg plus 0.5% heavy marcaine 3.5 ml

Intervention: Morphine

spinal morphine 0.1 mg

spinal morphine 0.1 mg plus 0.5% heavy marcaine 3.5 ml

Intervention: Morphine

Outcomes

Primary Outcomes

the amount of 24 hours morphine

Time Frame: 24 hour

Study Sites (1)

Loading locations...

Similar Trials